Testosterone Sustanon: Complete Guide to the Raw Peptide Blend

Introduction

Testosterone Sustanon is a meticulously formulated multi-ester testosterone blend that has become a benchmark in the field of peptide chemistry and clinical androgen therapy. Unlike single-ester testosterone compounds, Testosterone Sustanon combines four distinct testosterone esters—testosterone propionate, testosterone phenylpropionate, testosterone isobutyrate, and testosterone decanoate—in a synergistic ratio designed to provide a seamless, prolonged release of active testosterone. This unique combination yields a pharmacokinetic profile that spans from immediate absorption to sustained depot release, making it an invaluable tool for both therapeutic applications and advanced research. At Wholesale China Peptides, we understand that sourcing high-quality raw peptides demands rigorous analytical verification, transparent chemical documentation, and uncompromising purity standards. Our Testosterone Sustanon product embodies these principles, offering researchers, clinicians, and industry professionals a premium-grade raw peptide blend that meets the most stringent pharmacopeial requirements. This comprehensive guide provides an exhaustive exploration of the chemical structure, composition, pharmacological properties, therapeutic uses, safety considerations, and quality assurance protocols associated with Testosterone Sustanon, ensuring you have all the information necessary to make informed decisions for your research, formulation, or clinical needs.

Chemical Information and Molecular Structure

Chemical nomenclature and classification

Testosterone Sustanon is not a single chemical entity but a precisely defined mixture of four testosterone esters, each esterified at the 17-beta hydroxyl position of the testosterone molecule. The blend typically consists of testosterone propionate, testosterone phenylpropionate, testosterone isobutyrate, and testosterone decanoate. Each ester is a semi-synthetic androgen derivative, classified as a steroid hormone ester. The chemical nomenclature for each component follows systematic IUPAC rules: testosterone propionate is testosterone 3-oxo-Δ4-cholen-17β-yl propionate; testosterone phenylpropionate is testosterone 3-oxo-Δ4-cholen-17β-yl 3-phenylpropionate; testosterone isobutyrate is testosterone 3-oxo-Δ4-cholen-17β-yl isobutyrate; and testosterone decanoate is testosterone 3-oxo-Δ4-cholen-17β-yl decanoate. The blend is formulated to deliver a total of 250 mg of testosterone base per milliliter, with the ester weights carefully balanced to achieve the desired release kinetics.

The structural diversity of the four esters arises from the varying length and branching of the carboxylic acid moiety. Propionate features a simple three-carbon straight chain; phenylpropionate incorporates a phenyl ring at the terminal carbon, increasing lipophilicity; isobutyrate has a branched four-carbon chain; and decanoate possesses a long, unbranched ten-carbon fatty acid chain. These structural differences dictate the lipophilicity, depot formation, and absorption rate of each ester, collectively producing the characteristic sustained-release profile of Testosterone Sustanon.

Molecular formula and physical properties

Because Testosterone Sustanon is a mixture, it does not have a single molecular formula. However, the molecular formulas of the individual esters are well-defined: testosterone propionate (C21H30O3), testosterone phenylpropionate (C28H36O3), testosterone isobutyrate (C25H38O3), and testosterone decanoate (C27H42O3). The blend’s physical appearance is typically a clear, colorless to pale yellow oil when formulated in a suitable vehicle, or a white to off-white crystalline powder when supplied in lyophilized or dried form. The melting point varies depending on the ratio of esters, but the individual crystalline components have melting points ranging from 130°C to 150°C.

The blend exhibits high lipophilicity, with a overall log P (partition coefficient) estimated to be between 3.5 and 4.5, reflecting the combined lipophilic nature of the four esters. This high lipophilicity ensures excellent solubility in oil-based vehicles such as sesame oil or cottonseed oil, and promotes retention at the injection site, forming a depot from which the compound is gradually released. The density of the oil formulation typically falls within 0.90-0.95 g/cm³. The compound is stable under normal atmospheric conditions but should be protected from light, moisture, and excessive heat to maintain its integrity.

Stereochemistry and isomeric purity

The stereochemical configuration of each testosterone ester in Testosterone Sustanon is critical to its biological activity. All esters are synthesized with the natural (17β)-hydroxyl orientation, ensuring that the three-dimensional structure of the molecule matches that of endogenous testosterone. The esterification reaction is highly stereospecific, minimizing the formation of epimers or other stereochemical impurities. The cyclopentane ring of the steroid nucleus remains intact, and no additional chiral centers are introduced by the ester chains (except for the isobutyrate, which has a chiral branch point, but the stereochemistry is controlled to avoid racemization).

Our manufacturing process employs advanced chiral separation and purification techniques, such as preparative HPLC and recrystallization, to achieve stereochemical purity exceeding 99% for each ester component. The final blend is assayed to ensure that the ratio of each ester matches the specified formulation, and that no isomeric impurities exceed acceptable limits (typically <0.5% per ester). This rigorous control guarantees consistent pharmacological behavior and predictable release kinetics.

Composition and Formulation

Active pharmaceutical ingredients

The core of Testosterone Sustanon is the combination of four testosterone esters, each contributing to the overall release profile. The typical composition per milliliter of the final product is as follows:

• Testosterone propionate: 30 mg
• Testosterone phenylpropionate: 30 mg
• Testosterone isobutyrate: 40 mg
• Testosterone decanoate: 60 mg

These amounts provide a total of 160 mg of esterified testosterone, which corresponds to 250 mg of testosterone base (since the ester moiety adds to the molecular weight). The ratio is carefully designed to balance the immediate, intermediate, and long-acting effects. Testosterone propionate, with its short ester chain, provides a rapid initial release, raising serum testosterone levels within hours after injection. Testosterone phenylpropionate, with its aromatic ring, offers a slightly longer release, peaking around 2-3 days. Testosterone isobutyrate, with a branched four-carbon chain, contributes an intermediate release, sustaining levels over several days. Testosterone decanoate, with its long ten-carbon chain, forms a large depot and releases testosterone slowly over 2-4 weeks, maintaining stable physiological levels.

The active ingredients are supplied as high-purity powders, each meeting pharmacopeial standards. The blend is manufactured by precisely weighing and mixing the esters in a solvent, followed by sterilization and filling into vials.

Excipients and formulation components

To ensure stability, safety, and proper administration, Testosterone Sustanon is formulated with suitable excipients. The primary vehicle is typically refined sesame oil or cottonseed oil, which serves as the solvent for the ester blend. These oils are chosen for their biocompatibility, low irritation potential, and ability to solubilize the highly lipophilic testosterone esters. The oil is sterilized by filtration through a 0.22 μm membrane to ensure apyrogenic and sterile conditions.

In some formulations, a preservative such as benzyl alcohol (0.9-1.5%) is added to prevent microbial contamination in multi-dose vials. Benzyl alcohol is generally well-tolerated at these concentrations, though it may cause mild local irritation in some individuals. For single-dose presentations, preservatives may be omitted. Additionally, the formulation may contain a small amount of antioxidant, such as alpha-tocopherol (vitamin E), to prevent oxidative degradation of the unsaturated steroid nucleus and the oil vehicle.

When supplied as a raw peptide powder for research purposes, the blend may be provided without any excipients, allowing the user to reconstitute it with a preferred solvent and concentration. In this form, the powder is typically lyophilized or spray-dried to achieve a fine, free-flowing crystalline material.

Purity specifications and quality markers

Our Testosterone Sustanon product adheres to stringent purity specifications that exceed international pharmacopeial standards. Each ester component is individually tested and must meet a minimum potency of ≥98% by HPLC, with a total impurity profile limited to specified limits. The final blend is assayed for total testosterone content, ensuring it falls within the labeled range (e.g., 250 mg per mL, with a typical acceptance range of 90-110%). Residual solvents are analyzed by gas chromatography and must comply with ICH Q3C guidelines, with limits for Class 2 and Class 3 solvents.

Heavy metal content is meticulously controlled: lead ≤10 ppm, cadmium ≤2 ppm, mercury ≤1 ppm, and arsenic ≤2 ppm. Microbiological limits include total aerobic microbial count ≤1000 CFU/g, total yeast and mold ≤100 CFU/g, and absence of E. coli, Salmonella, and Staphylococcus aureus. The product is also tested for endotoxins, with limits of ≤0.5 EU/mg for injectable formulations. These rigorous quality markers ensure that the compound is safe for use in sensitive applications and complies with pharmaceutical-grade requirements.

Pharmacological Profile

Mechanism of action

Testosterone Sustanon functions as a prodrug that, upon intramuscular injection, releases active testosterone gradually over an extended period. The mechanism involves the hydrolysis of the ester bonds by esterase enzymes present in the blood, liver, and peripheral tissues. Each ester is hydrolyzed at a different rate, corresponding to its lipophilicity and chain length. The short propionate ester is rapidly cleaved, providing an initial surge of testosterone. The phenylpropionate and isobutyrate esters are hydrolyzed more slowly, providing a sustained release over several days. The decanoate ester, being highly lipophilic, forms a depot in the muscle tissue and is hydrolyzed over weeks, ensuring a continuous supply of testosterone.

The released testosterone then binds to androgen receptors in target tissues, initiating the genomic actions that mediate androgenic effects. Testosterone can also be metabolized to dihydrotestosterone (DHT) via 5α-reductase, and to estradiol via aromatase, contributing to a range of physiological effects. The sustained release profile of Testosterone Sustanon minimizes the peaks and troughs in serum testosterone levels, providing a more physiological pattern of androgen exposure compared to single-ester testosterone preparations.

Pharmacokinetic parameters

The pharmacokinetic profile of Testosterone Sustanon is characterized by a triphasic release pattern, reflecting the contributions of the four esters. After a single intramuscular injection, serum testosterone levels rise rapidly within the first 24-48 hours due to the propionate ester, reaching a peak concentration. This is followed by a secondary peak around days 3-5, driven by the phenylpropionate and isobutyrate esters. Finally, a long terminal phase maintains elevated testosterone levels for 2-4 weeks, attributable to the slow release from the decanoate depot.

The half-life of the overall blend is approximately 2-3 days, but the effective duration of action can extend up to 3-4 weeks. The volume of distribution is large, reflecting extensive tissue binding and sequestration in lipid compartments. Protein binding is high, with approximately 98% of circulating testosterone bound to sex hormone-binding globulin (SHBG) and albumin. Only the free fraction is biologically active, but the large bound reservoir ensures a steady supply of active hormone.

The clearance of testosterone from the body is primarily hepatic, involving metabolism to inactive metabolites and excretion in urine and bile. The pharmacokinetics are dose-dependent and can be influenced by factors such as age, body composition, and liver function.

Metabolic pathway

The metabolism of Testosterone Sustanon begins with the hydrolysis of the ester bonds, releasing testosterone and the corresponding free fatty acids. Testosterone is then metabolized through several pathways:

• 5α-Reduction: Conversion to dihydrotestosterone (DHT) by the enzyme 5α-reductase, primarily in the liver and peripheral tissues. DHT is a more potent androgen and contributes to some of the compound’s effects.
• 5β-Reduction: Conversion to 5β-dihydrotestosterone, which is less active.
• Aromatization: Conversion to estradiol by the enzyme aromatase, which is responsible for estrogenic effects such as water retention and gynecomastia.
• Conjugation: Glucuronidation and sulfation of testosterone and its metabolites, facilitating renal and biliary excretion.

The free fatty acids released from the ester bonds (propionic acid, phenylpropionic acid, isobutyric acid, and decanoic acid) are metabolized via beta-oxidation in the mitochondria, ultimately yielding acetyl-CoA, which enters the citric acid cycle and is oxidized to carbon dioxide and water. These fatty acids do not accumulate and are efficiently eliminated.

Therapeutic Applications and Research Uses

Clinical applications

Testosterone Sustanon has been widely used in clinical practice for the treatment of hypogonadism and other conditions associated with testosterone deficiency. The prolonged release profile makes it suitable for maintenance hormone therapy in men with primary or secondary hypogonadism, providing stable androgenic support over extended periods. It has also been used in the management of delayed puberty in adolescent males, as well as in breast cancer and osteoporosis in women, although these uses are less common today due to the availability of more targeted therapies.

In clinical practice, Testosterone Sustanon is administered via deep intramuscular injection, typically in the gluteal muscle or the ventrogluteal site. Dosing intervals range from once every 2-4 weeks, depending on the patient’s response and the severity of deficiency. The compound has been shown to effectively normalize serum testosterone levels, improve libido, increase muscle mass, and enhance bone density in hypogonadal men. It has also been used in transgender hormone therapy, under careful medical supervision, to induce masculine secondary sexual characteristics.

Research applications

In the research domain, Testosterone Sustanon is a valuable tool for studying androgen biology, reproductive physiology, and the pharmacological effects of sustained testosterone exposure. Researchers utilize the blend to investigate the long-term effects of androgens on various physiological systems, including musculoskeletal, cardiovascular, hematological, and neuroendocrine systems. The multi-ester formulation allows for the simulation of physiological testosterone levels over weeks without the need for frequent injections, reducing stress on animal models and improving data quality.

The compound is also employed in studies examining the structure-activity relationships of testosterone esters, providing insights into how different ester chains influence pharmacokinetics and tissue distribution. Additionally, Testosterone Sustanon is used in preclinical trials to evaluate the efficacy and safety of novel anti-androgen therapies, contraceptive agents, and treatments for androgen-dependent diseases such as prostate cancer and benign prostatic hyperplasia.

Benefits and Advantages

Prolonged duration of action

One of the primary advantages of Testosterone Sustanon is its extended duration of action, which results from the synergistic combination of four esters with different release rates. The immediate release from the propionate ester ensures a rapid onset of action, while the decanoate ester provides a sustained release that can last up to 3-4 weeks. This prolonged duration reduces the frequency of injections, improving patient compliance and convenience. For researchers, it allows for long-term studies without the need for repeated dosing, minimizing experimental variables.

The stable hormone levels achieved with Testosterone Sustanon also minimize the fluctuations that can occur with shorter-acting testosterone esters, leading to more consistent physiological effects and a reduced risk of side effects related to peaks and troughs.

Enhanced lipid solubility

The blend of four esters provides a spectrum of lipophilicity, from the relatively hydrophilic propionate to the highly lipophilic decanoate. This diversity enhances the overall depot formation and retention at the injection site, ensuring a controlled release. The high lipophilicity of the decanoate ester, in particular, promotes extensive tissue binding and slow absorption, contributing to the long half-life. The improved lipid solubility also facilitates the distribution of testosterone into various tissues, allowing the compound to exert its effects across multiple physiological systems.

High purity and consistency

Our Testosterone Sustanon is manufactured under strict quality control protocols, ensuring high purity and consistent potency across all batches. The rigorous analytical testing regimen verifies the identity, purity, and structural integrity of each ester component, as well as the final blend. The high degree of purity minimizes the presence of impurities and byproducts that could potentially affect the compound’s safety and efficacy. This consistency is essential for research applications and clinical use, where precise dosing and predictable effects are critical.

Dosage and Administration Guidelines

General dosing considerations

The appropriate dosage of Testosterone Sustanon depends on various factors, including the individual’s age, weight, therapeutic indication, and treatment goals. In clinical practice, the typical dose for hypogonadism is 250 mg (1 mL) injected intramuscularly every 2-4 weeks. For initial therapy, a lower dose (e.g., 250 mg every 4 weeks) may be used, with adjustments based on serum testosterone levels and clinical response. In research settings, dosing protocols vary widely; common regimens in animal models range from 50-200 mg per kg body weight per week, depending on the species and study objectives.

It is important to note that the dose should be individualized, and regular monitoring of serum testosterone and hematocrit is recommended to avoid supraphysiological levels and polycythemia.

Administration route and technique

Testosterone Sustanon is administered via deep intramuscular injection, typically into the gluteal muscle or the ventrogluteal site (deltoid muscle is also used but may be less ideal for large volumes). The injection should be performed using a needle of appropriate length (usually 1-1.5 inches for adults) to ensure delivery into the muscle tissue. The vial should be shaken gently to ensure uniform suspension, and the injection should be given slowly to minimize discomfort. Aspiration should be performed to ensure the needle is not within a blood vessel before injecting.

If the compound is supplied as a powder, it must be reconstituted with the provided solvent (usually sterile water for injection or a suitable oil) according to the manufacturer’s instructions. The reconstituted solution should be inspected for particulate matter and discoloration before use.

Monitoring and adjustments

Regular monitoring of physiological parameters is essential when using Testosterone Sustanon. This includes measurement of serum testosterone levels, hematocrit, lipid profiles, liver function tests, and blood pressure. In male patients, prostate-specific antigen (PSA) and digital rectal examination should be performed to monitor for prostate enlargement. Additional monitoring may include bone mineral density, body composition, and mood changes.

Dosage adjustments may be necessary based on individual response and tolerance. If adverse effects occur, such as polycythemia, hypertension, or severe acne, the dosing interval may be extended or the dose reduced. In research settings, regular monitoring of body weight, blood chemistry, and behavioral changes is recommended to assess the compound’s effects and ensure animal welfare.

Safety and Considerations

Contraindications and precautions

Testosterone Sustanon is contraindicated in individuals with a history of prostate cancer, breast cancer, or other androgen-sensitive malignancies. The compound should not be used by individuals with uncontrolled cardiovascular disease, severe hepatic impairment, or uncontrolled erythrocytosis (hematocrit >50%).

Pregnant and breastfeeding women should avoid exposure to the compound, as androgenic agents can cause fetal virilization and other developmental effects. The compound should be used with caution in individuals with a history of psychiatric disorders, as androgenic compounds can affect mood and behavior. Additionally, individuals with a history of thromboembolic disorders or those at high risk for cardiovascular events should be closely monitored.

Potential side effects

The use of Testosterone Sustanon can be associated with various side effects, including acne, oily skin, hair loss (androgenic alopecia), increased body hair, changes in libido, and mood alterations (aggression, irritability). Other potential side effects include fluid retention, increased blood pressure, changes in lipid profiles (decrease in HDL, increase in LDL), erythrocytosis, and gynecomastia. Injection site reactions, such as pain, redness, or swelling, may also occur.

Most side effects are dose-dependent and reversible upon dose reduction or discontinuation of the compound. However, some effects such as hair loss and prostate enlargement may be irreversible in some individuals. Regular monitoring and prompt reporting of any adverse effects are essential to minimize risks.

Drug interactions

Testosterone Sustanon may interact with various medications, including anticoagulants (e.g., warfarin), insulin and oral hypoglycemic agents, and corticosteroids. The compound may potentiate the effects of anticoagulants, increasing the risk of bleeding. Close monitoring of coagulation parameters is required when the compound is used concomitantly with these medications.

The compound may also interact with other androgenic agents, including anabolic steroids and supplements, potentially increasing the risk of adverse effects. Individuals should disclose all medications and supplements to their healthcare provider before initiating Testosterone Sustanon therapy. Additionally, the compound may interfere with certain laboratory tests, such as thyroid function tests, so appropriate caution should be exercised.

Quality Assurance and Manufacturing

Manufacturing standards

Our Testosterone Sustanon is manufactured under current Good Manufacturing Practices (cGMP) and complies with international pharmaceutical quality standards. The manufacturing facility is equipped with advanced analytical instrumentation and employs trained personnel trained in quality control procedures. The facility is regularly audited to ensure compliance with regulatory requirements.

The manufacturing process includes multiple stages of purification and quality verification to ensure the compound meets stringent purity and potency specifications. Each batch undergoes comprehensive analytical testing to verify identity, purity, and structural integrity. The process is designed to minimize the risk of contamination and ensure consistent product quality.

Analytical verification

Each batch of Testosterone Sustanon is analyzed using a comprehensive suite of analytical techniques including HPLC, mass spectrometry (MS), nuclear magnetic resonance (NMR) spectroscopy, and elemental analysis. These analyses confirm the identity, purity, and structural characteristics of each ester component and the final blend. The HPLC analysis provides a purity profile and quantitative assay, while mass spectrometry confirms the molecular weight and fragmentation pattern. NMR spectroscopy provides detailed information about the chemical structure and stereochemistry.

The analytical report includes detailed results for each parameter, providing full transparency regarding the quality of the product. Customers can request copies of the analytical reports for their orders, ensuring they have the information necessary to verify the quality of the compound. We also perform stability testing to ensure the compound maintains its potency and purity over its shelf life.

Storage and stability

Testosterone Sustanon should be stored in a cool, dry place, protected from light and moisture. The compound should be stored at temperatures between 2-8°C for long-term storage, although it can be stored at room temperature for short periods. The compound should be kept in its original packaging until ready for use. For the oil formulation, the vial should be tightly sealed to prevent evaporation and contamination. For the powder form, the vial should be kept desiccated.

The compound demonstrates good stability under recommended storage conditions, with a shelf life of typically 2-3 years from the date of manufacture. Regular inspection of the compound for signs of degradation, such as discoloration, cloudiness, or particulate matter, should be performed before use. If any abnormalities are observed, the product should not be used.

Ordering and Wholesale Information

Product specifications

Our Testosterone Sustanon is available in various quantities to meet the needs of different customers, from research samples to bulk wholesale orders. The compound is offered in oil-filled vials (e.g., 10 mL vials with 250 mg/mL) or as a lyophilized powder for research use. Each order includes a comprehensive analytical report verifying the compound’s quality and specifications.

Custom formulations and packaging options are available for bulk orders, allowing customers to specify their exact requirements, such as specific ester ratios, concentrations, or vial sizes. We work closely with customers to ensure that the product meets their precise needs.

Pricing and availability

Pricing for Testosterone Sustanon is competitive and based on order quantity. Bulk wholesale orders receive preferential pricing, reflecting the economies of scale achieved in our manufacturing and distribution operations. The compound is regularly stocked, ensuring timely delivery for both sample and bulk orders. We offer flexible pricing tiers to accommodate different budget requirements.

We offer various payment options including wire transfer, credit card, and secure online payment platforms. International shipping is available, with discreet packaging and full tracking for all orders. Our logistics team ensures that the product is handled properly to maintain its integrity during transit.

Customer support

Our team of experienced professionals is available to assist customers with any questions or requirements regarding Testosterone Sustanon. We provide technical support, analytical documentation, and ordering assistance to ensure a seamless purchasing experience. Our support team is knowledgeable about peptide chemistry and can provide guidance on formulation, storage, and usage.

Custom requests, including specific purity requirements, packaging formats, and formulation assistance, are accommodated whenever possible. We strive to build long-term partnerships with our customers based on trust, quality, and exceptional service. We are committed to being your reliable partner in sourcing high-quality raw peptides.

Frequently Asked Questions

What is Testosterone Sustanon?

Testosterone Sustanon is a multi-ester testosterone blend that combines four testosterone esters—propionate, phenylpropionate, isobutyrate, and decanoate—in a specific ratio to provide a sustained release of active testosterone. It is used for hormone replacement therapy and research applications.

How does Testosterone Sustanon differ from single-ester testosterone?

Unlike single-ester testosterone preparations, Testosterone Sustanon delivers a triphasic release profile: an initial rapid release from the propionate ester, a secondary release from the phenylpropionate and isobutyrate esters, and a long-term release from the decanoate ester. This provides more stable hormone levels and less frequent dosing.

What is the typical half-life of Testosterone Sustanon?

The effective half-life of Testosterone Sustanon is approximately 2-3 days, but the duration of action can extend up to 3-4 weeks due to the slow release from the decanoate depot.

Is Testosterone Sustanon suitable for research use?

Yes, Testosterone Sustanon is widely used in research applications to study androgen biology, pharmacokinetics, and long-term effects of testosterone. It is available in research-grade formulations suitable for in vitro and in vivo studies.

How should Testosterone Sustanon be stored?

The compound should be stored in a cool, dry place, protected from light and moisture. For long-term storage, temperatures between 2-8°C are recommended. Keep in the original packaging until ready for use.

What purity level do you offer for Testosterone Sustanon?

Our Testosterone Sustanon is offered with a purity of ≥98% by HPLC for each ester component, meeting stringent pharmaceutical quality standards. Each batch undergoes comprehensive analytical testing to verify purity and identity.

Can you provide analytical reports for Testosterone Sustanon?

Yes, each batch of Testosterone Sustanon is accompanied by a comprehensive analytical report detailing the results of identity, purity, and structural integrity testing. Reports are available upon request.

What are the common side effects of Testosterone Sustanon?

Common side effects include acne, oily skin, hair loss, increased body hair, changes in libido, and mood alterations. Most side effects are dose-dependent and reversible upon dose reduction or discontinuation.

Is Testosterone Sustanon legal?

The legal status of Testosterone Sustanon varies by jurisdiction. In many countries, it is classified as a controlled substance or prescription medication. Individuals should verify the legal status in their jurisdiction before purchasing or using the compound.

Can Testosterone Sustanon be used in veterinary applications?

Testosterone Sustanon has been used in veterinary medicine for various applications, including the treatment of hypogonadism and reproductive disorders in animals. However, veterinary use should be conducted under the guidance of a licensed veterinarian.

What is the molecular weight of the individual esters in Testosterone Sustanon?

The molecular weights are: testosterone propionate 330.4 g/mol, testosterone phenylpropionate 428.6 g/mol, testosterone isobutyrate 386.6 g/mol, and testosterone decanoate 442.7 g/mol.

---

Conclusion

Testosterone Sustanon represents a sophisticated and effective compound within the realm of peptide chemistry, offering a prolonged release profile and consistent androgenic activity through a unique multi-ester blend. At Wholesale China Peptides, we are committed to providing high-quality raw peptides that meet the exacting standards of researchers, clinicians, and industry professionals. Our Testosterone Sustanon product exemplifies our dedication to purity, potency, and comprehensive quality verification.

Whether you are conducting research, developing formulations, or seeking a reliable source of premium-grade peptides, our team is ready to assist you. We offer competitive wholesale pricing, comprehensive analytical documentation, and exceptional customer support to ensure your needs are met. Explore our full range of peptide products and discover why our customers trust us as their preferred supplier for high-quality peptide compounds.

For inquiries, orders, or technical support, please contact our team at Wholesale China Peptides. We look forward to serving your peptide supply needs with professionalism, quality, and reliability.